A May 21 article in The Washington Post’s Health 202 column on prescription drug pricing includes remarks from health care partner Tom Bulleit (Washington, D.C.), describing several different strategies that state legislatures have been taking to provide more regulation of pharmacy benefit managers, key “middlemen” in the drug supply chain that President Trump has stated his administration plans to make less “rich” as part of its 4-point plan to reduce prescription drug prices.
Attorneys

Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.